Corporate Snapshot
Company Overview
The Calmer Co provides natural solutions to calm nerves, support mind and muscle relaxation and induce sleep.
Markets: USA, Australia, NZ, Fiji, China
Brands: Fiji Kava, Taki Mai, Danodan Hempworks
Products: Powders, Capsules, Teas, Dietary Shots
Stock Overview
CCO.ASX
ASX Ticker Code
Automic
Share Registry
Recent Highlights
- $4.4m H1 FY25 Sales surpassing full year FY24 in the first two quarters, representing +300% vs PCP.
- $2.6m Q2 FY25 Cash Receipts, +270% vs PCP
- $675k of inventory built in Q2 bringing the company’s inventory position to $2.2m (>$4m at sales value) with factory upgrade underway.
- Net Cash used in operations was cut by half, after inventory built is taken into account, cash utilised for operations was $142k per month in FY25 Q2 down from $284k per month in Q1.
- Coles now stocks our products in 846 supermarkets nationally and have expanded SKUs to 2,183 listings.
- Retail store sales now account for almost 25% of total sales.
- USA launch in progress.
- Walmart.com has launched Fiji Kava instant drinking kava
- Navua processing facility upgrade in progress in order to 3X our manufacturing capacity
- 22 Quikstop stores now distribute TakiMai shots
- Leilo distribution deal has commenced via the resorts channel in Fijian islands
- Metagenics to launch Kava Sleep made with Fiji Kava kavaton.
Pitt Street Research Analyst Report
Pitt Street Research has released an update to its research report on The Calmer Co which sets base case valuation of $0.016 per share and a bull case valuation range of $0.018-$0.024 per share.
Highlights from the Research Report
- Market capitalisation is $59.5m in the base case and $77.5m in the bull case.
- Calmer Co. finished FY24 with $4.3m in sales, a figure that was more than double FY23 sales
- In the first 6 months of FY25, the company has already surpassed FY24’s figures and recorded an annualised revenue rate of $10m in the month of October 2024.
- The company reduced net cash used in operations by half in Q2, after inventory was accounted for, with cash burn of $142k per month, down from $284k per month in Q1 of FY25.
Our Value Proposition
Leveraging a global opportunity in natural products that aid relaxation, anxiety and sleep.
- Diversified across brands, products and ingredients
- Delivering strong sales growth
- A true vertical supply chain from farm to shelf
- Partnered with blue chip retailers and distributors
- A medicinal product that works and is validated by science*
The Calmer Co. Vision
The Calmer Co aims to create natural products that calm mind and body and deliver these products to a global market.
The next blockbuster functional beverage!
Drive exponential growth in ready to drink kava based products worldwide.
It’s natural, it works, it tastes great, it’s low calorie, low sugar and it’s on trend.
Diversify our range with new products and ingredients
We are leveraging the global movement in calmness. We started in kava. We see further opportunity in CBD (hemp), ginger, curcumin, magnesium and more. Delivered as beverages, powders, shots, teas and gummies.
Low cost manufacturing feeding a global sales network
Growing and refining ingredients in our low cost base region of Fiji and distributing great products through our house of brands to the world as powders, syrups and oils.